Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line
<p>Abstract</p> <p>Background</p> <p>Bcl-2 and Bcl-XL are anti-apoptotic paralogues that inhibit apoptosis elicited by a wide variety of stimuli, and play critical roles in cancer development and resistance to treatment. Many clinical studies have indicated that express...
Main Authors: | Leber Brian, Hollerbach Catherine, Zhu Weijia, Fiebig Aline A, Andrews David W |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-08-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/213 |
Similar Items
-
Bcl-XL inhibits membrane permeabilization by competing with Bax.
by: Lieven P Billen, et al.
Published: (2008-06-01) -
Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2
by: Qian Liu, et al.
Published: (2019-03-01) -
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
by: Reut Yosef, et al.
Published: (2016-04-01) -
Bcl-xL in neuroprotection and plasticity
by: Elizabeth Ann Jonas, et al.
Published: (2014-09-01) -
The role of Helicobacter pylori CagA in regulation of Bcl-2, Bcl-xL and Bcl-6
by: Li-Pu Huang, et al.
Published: (2010)